First, in terms of renal protection, SGLT-2 inhibitors inhibit glomerular hyperfiltration by increasing glomerular inflow, reducing kidney pressure, delaying kidney function deterioration, and decreasing urinary protein excretion, thereby reducing kidney damage (102). The gene discussed is SLC5A2; the disease is Nephropathy.